» Centro de Vigilancia y Seguridad de Medicamentos › Departamento de Farmacología y Toxicología   
Universidad de Buenos Aires Sitio de la Facultad de Medicina
  › Home del Centro
  › Misión y Objetivos
  › Organización
  › Historia
  › Sec. Farmacovigilancia     Proactiva y Análisis     Estadístico de Datos
  › Sección Información de     Medicamentos
  › Lab. de Seguridad     Cardiovascular de     Fármacos
  › Lab. Farmacocinética,     Farmacogenómica y     Medicina Personalizada
  › Sección Historia de     los Medicamentos
  › Producción y Logros
      › Articulos
      › Congresos
      › Libros y Capítulos
      › Premios
      › Capacitación
      › Proyectos/Subsidios
      › Otros
 
Artículos publicados
 
2016:
  • Bril F, Castro V, Gomez Centurion I, Espinosa J, Keller GA, Gonzalez CD, Soler C, Lopez Saubidet C, Di Girolamo G, Alvarez PA. Assessing the Burden of Drug Interactions in Kidney Transplant Patients. Curr Drug Saf. 2016;11(2):156-63. PDF PDF
  • Keller GA, Villa Etchegoyen MC, Fernandez N, Olivera NM, Quiroga PN, Belloso WH, Diez RA, Di Girolamo G. Meperidine Induced QTc-Interval Prolongation: Prevalence, Risk Factors and Correlation to Plasma Drug and Metabolite Concentrations. Curr Drug Saf. 2016; in press. PDF PDF
  • Keller GA, Villa Etchegoyen MC, Fernandez N, Olivera NM, Quiroga PN, Belloso WH, Diez RA, Di Girolamo G. Tramadol Induced QTc-Interval Prolongation: Prevalence, Clinical Factors and Correlation to Plasma Concentrations. Curr Drug Saf. 2016; in press. PDF PDF
  • Farias J, Keller GA, Papouchado M, Criscuolo ME, Diez RA, Di Girolamo G. Relative bioavailability between two teriparatide formulations in healthy volunteers. Int J Clin Pharmacol Ther 2016; 54(8):649-56. PDF PDF
  • Keller GA, Czerniuk P, Bertuola R, Villa Etchegoyen MC, Mendez M, Gimenez MI, Di Girolamo G. Comparative bioavailability of 2 tablet formulations of emtricitabine /tenofovir in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Int J Clin Pharmacol Ther 2016; 54(1); in press. PDF PDF
  • Keller GA, Alvarez PA, Ponte ML, Belloso WH, Bagnes C, Gonzalez CD, Villa Etchegoyen MC, Diez RA, Di Girolamo G. Drug-induced QTc interval prolongation: A multicenter study to detect drugs and clinical factors involved in every day practice. Curr Drug Saf. 2016;11:86-98. PDF PDF
2015:
  • Oliveri B, Mastaglia SR, Brito GM, Seijo M, Keller GA, Somoza J, Diez RA, Di Girolamo G. Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach. Eur J Clin Nutr. 2015;69(6):697-702. PDF PDF
2014:
  • Keller GA, Fabian L, Gomez M, Gonzalez CD, Diez RA, Di Girolamo G. Age-Distribution and genotype / phenotype correlation for N-acetyltransferase in Argentine children under isoniazid treatment. Int J Clin Pharmacol Ther 2014; 52(4): 292-302. PDF PDF
2013:
  • Alvarez PA, Bril F, Castro V, Meiville I, Gonzalez CD, Gomez Centurion I, Parejas G, Soler Riera C, Lopez Saubidet C, Di Girolamo G, Keller GA. Adverse Drug Reactions as a Reason for Admission to an Internal Medicine Ward in Argentina. Int J Risk Saf Med 2013; 25(3):185-92. PDF PDF
2012:
  • Alvarez PA, Egozcue J, Sleiman J, Moretti L, Di Girolamo G, Keller GA. Severe neutropenia in a renal transplant patient suggesting an interaction between mycophenolate and fenofibrate. Curr Drug Saf 2012;7(1):24-9. PDF PDF
2011:
  • Keller GA, Di Girolamo G, Alvarez PA. Pharmacovigilance and the cardiovascular system: two sides to every story. Curr Drug Saf 2011;6(4):224-9. PDF PDF
  • Keller GA, Czerniuk P, Bertuola R, de Mena F, Simoni MV, Assefi AR, Di Girolamo G. Relative bioavailability of a 5 mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers: a single-dose randomized open-label crossover study. Curr Med Res Opin 2011;27(11):2203-11. PDF PDF
  • Keller GA, Czerniuk P, Bertuola R, Spatz JG, Assefi AR, Di Girolamo G. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Clin Ther 2011;33(4):500-10. PDF PDF
  • Altman R, Scazziota AS, Pons S, Herrera L, Keller GA, Assefi AR, Di Girolamo G. Effects of enoxaparin preparations on thrombin generation and their correlation with their anti-FXa activity. Curr Med Res Opin. 2011 Jan;27(1):1-9. PDF PDF
2010:
  • Di Girolamo G, Czerniuk P, Bertuola R, Keller GA. Bioequivalence of Two Tablet Formulations of Clopidogrel in Healthy Argentinian Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study. Clinical Therapeutics 2010; 32(1):161-170. PDF PDF
  • Di Girolamo G. Drug-induced at interval prolongation: clinical, safety and regulatory updaes. Curr Drug Saf. 2010;5(1):41-3. PDF
  • Ponte ML, Keller GA, Di Girolamo G. Mechanisms of drug induced QT interval prolongation. Curr Drug Saf. 2010;5(1):44-53. PDF PDF
  • Giorgi MA, Bola˝os R, Gonzalez CD, Di Girolamo G. QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications. Curr Drug Saf. 2010;5(1):54-7. PDF
  • Keller GA, Di Girolamo G. Antihistamines: past answers and present questions. Curr Drug Saf. 2010;5(1):58-64. PDF PDF
  • Taira CA, Opezzo JA, Mayer MA, H÷cht C. Cardiovascular drugs inducing QT prolongation: facts and evidence. Curr Drug Saf. 2010;5(1):65-72. PDF
  • Keller GA, Di Girolamo G. Prokinetic agents and QT prolongation: a familiar scene with new actors. Curr Drug Saf. 2010;5(1):73-8. PDF PDF
  • Gonzalez CD, de Sereday M, Sinay I, Santoro S. Endocrine therapies and QTc prolongation. Curr Drug Saf. 2010;5(1):79-84. PDF
  • Bril F, Gonzalez CD, Di Girolamo G. Antimicrobial agents-associated with QT interval prolongation. Curr Drug Saf. 2010;5(1):85-92. PDF
  • Bagnes C, Panchuk PN, Recondo G. Antineoplastic chemotherapy induced QTc prolongation. Curr Drug Saf. 2010;5(1):93-6. PDF
  • Alvarez PA, Pahissa J. QT alterations in psychopharmacology: proven candidates and suspects. Curr Drug Saf. 2010;5(1):97-104. PDF
  • Keller GA, Ponte ML, Di Girolamo G. Other drugs acting on nervous system associated with QT-interval prolongation. Curr Drug Saf. 2010;5(1):105-11. PDF PDF
2008:
  • Di Girolamo G, Keller GA, de los Santos AR, Schere D, Gonzalez CD. Bioequivalence of Two Levothyroxine Tablet Formulations Without and With Mathematical Adjustment for Basal Thyroxine Levels in Healthy Argentinian Volunteers: A Single-Dose, Randomized, Open-Label, Crossover Study. Clinical Therapeutics 2008;30(11):2015-23. PDF PDF
  • Di Girolamo G, Kauffman MA, Gonzalez E, Papouchado M, Ramirez A, Keller G, Carbonetto C, Dabsys S, Vidal A, Sterin-Prync A, Diez RA. Bioequivalence of two subcutaneous pharmaceutical products of interferon beta 1a. Arzneimittel-Forschung 2008;58(4) 193-198. PDF PDF
2007:
  • Di Girolamo G, Opezzo JAW, Lopez MI, Schere F, Keller G, Gonzalez CD, de los Santos MC. Relative bioavailability of new formulation of paracetamol effervescent powder containing sodium bicarbonate versus paracetamol tablets: a comparative pharmacokinetic study in fed subjects. Expert Opin Pharmacother 2007;8(15):1-9. PDF PDF
 
  Responsable de la página: Guillermo Alberto Keller Sugerencias y Consultas a: gkeller@fmed.uba.ar   
Sitio de la Facultad de Medicina